|
NDUFB10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.887600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.311200E-01 |
| Normal-vs-Stage2 |
8.666200E-01 |
| Normal-vs-Stage3 |
1.538160E-01 |
| Normal-vs-Stage4 |
8.620400E-01 |
| Stage1-vs-Stage2 |
5.062600E-01 |
| Stage1-vs-Stage3 |
4.765000E-01 |
| Stage1-vs-Stage4 |
6.657800E-01 |
| Stage2-vs-Stage3 |
3.228200E-01 |
| Stage2-vs-Stage4 |
7.873800E-01 |
| Stage3-vs-Stage4 |
2.998400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.344200E-01 |
| Normal-vs-AfricanAmerican |
2.202600E-01 |
| Normal-vs-Asian |
9.609000E-01 |
| Caucasian-vs-AfricanAmerican |
2.865800E-02 |
| Caucasian-vs-Asian |
8.156200E-01 |
| AfricanAmerican-vs-Asian |
5.806000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.808600E-01 |
| Normal-vs-Female |
8.095000E-01 |
| Male-vs-Female |
3.509800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.665000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.872200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.299800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.040400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.151400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.360400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.744000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.055200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.800850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.520000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.456000E-01 |
| Normal-vs-Grade 2 |
6.391600E-01 |
| Normal-vs-Grade 3 |
3.934400E-01 |
| Normal-vs-Grade 4 |
3.000800E-01 |
| Grade 1-vs-Grade 2 |
4.991800E-01 |
| Grade 1-vs-Grade 3 |
6.567000E-01 |
| Grade 1-vs-Grade 4 |
8.933600E-01 |
| Grade 2-vs-Grade 3 |
7.863000E-01 |
| Grade 2-vs-Grade 4 |
5.333800E-01 |
| Grade 3-vs-Grade 4 |
6.310400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.605200E-01 |
| Normal-vs-ccB subtype |
9.717300E-03 |
| ccA subtype-vs-ccB subtype |
5.016200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.891800E-01 |
| Normal-vs-N1 |
9.719400E-01 |
| N0-vs-N1 |
8.335000E-01 |
|
|
